JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO LTD has a total of 19 patent applications. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are Ab biosciences inc, SYSTIMMUNE INC and EUREKA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 1 | |
#5 | Hong Kong | 1 | |
#6 | Hungary | 1 | |
#7 | New Zealand | 1 | |
#8 | Russian Federation | 1 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Fermentation | |
#7 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Xu Ting | 19 |
#2 | Wang Xiaoxiao | 11 |
#3 | Wang Pilin | 8 |
#4 | Xu Tao | 6 |
#5 | Guo Kangping | 5 |
#6 | Li Qian | 5 |
#7 | Zhang Qingqing | 5 |
#8 | Jin Yuhao | 5 |
#9 | Pang Minjie | 4 |
#10 | Han Li | 4 |
Publication | Filing date | Title |
---|---|---|
WO2021073611A1 | Ox40/pd-l1 bispecific antibody | |
WO2021000953A1 | Substance and method for treating tumor | |
TW202003588A | Dimer and use thereof | |
CN110655582A | Bispecific antibodies or antibody mixtures with a common light chain |